Viewing Study NCT00663169

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:49 PM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT00663169
Status: COMPLETED
Last Update Posted: 2013-01-07
First Post: 2008-04-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis, Gouty View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Arthritis Gouty View
None ACZ885 View
None IL1B protein View
None Pain View